Xcout Intel
PROLIGHT DIAGNOSTICS
Prolight Diagnostics develops innovative point-of-care in-vitro diagnostic systems that utilize proprietary digital technology to perform blood tests and deliver reliable results within minutes. The company serves healthcare providers by enabling rapid biomarker detection and decentralized testing outside of traditional hospital laboratories.
Subscribe to see PROLIGHT DIAGNOSTICS’s full profile → the full roster, investors in every round, weekly hiring history and every corporate event
PROLIGHT DIAGNOSTICS at a glance
PROLIGHT DIAGNOSTICS is a medical devices company headquartered in United Kingdom. Xcout tracks 12 named people at PROLIGHT DIAGNOSTICS, including Karl Bullen (COO).
PROLIGHT DIAGNOSTICS leadership
- Karl BullenCOO
- Henrik LjungCFO
- Fredrik AlpstenStyrelseordförande
- Ulf BladinVD
- Steve RossCTO
- Paul MonaghanHead of Engineering
6 more named people on record for PROLIGHT DIAGNOSTICS, with roles, board committees and tenure — see the full roster →
PROLIGHT DIAGNOSTICS competitors
A few of PROLIGHT DIAGNOSTICS's closest competitors — see the full list of competitors and alternatives →
Pictura Bio is a medical technology company developing a one-minute pathogen detection platform utilizing proprietary hardware and computer vision for infectious disease diagnostics. Its point-of-care system, which includes the PIC-ID and VISTA reader technologies, provides rapid identification and differentiation of pathogens to assist frontline healthcare providers.
HemoCue AB develops and manufactures point-of-care medical diagnostic systems and testing equipment. The company serves healthcare providers in clinical settings, hospitals, blood banks, and public health sectors by offering portable devices for hematology, diabetes management, and infection detection.
Abbott Point of Care provides rapid diagnostic testing solutions and point-of-care medical devices for healthcare professionals.
PhotoniCare, Inc. is a medical equipment manufacturing company headquartered in Durham, North Carolina. The company is dedicated to revolutionizing frontline healthcare by delivering innovations such as its FDA-cleared OtoSight diagnostic device.
En Carta Diagnostics develops diagnostic products, including an FDA Breakthrough-designated Lyme disease test, to provide rapid and accurate medical testing for patients and healthcare providers.
Get PROLIGHT DIAGNOSTICS's news by email
Funding rounds, acquisitions, new executives, launches and expansions, each with a two-line summary and a link to the source. One short email a day, only when there is news.
Free: up to 5 companies, daily. Subscribers also follow whole sectors and saved filters (M&A in Israel, AI funding…), get instant alerts, in-app notifications and signed webhooks, and open the full profile behind every name. Subscribe →
Share this card
Post the link and the card appears automatically — each network fetches the image itself.
More on PROLIGHT DIAGNOSTICS in Xcout Intel
- 12 named people with titles, LinkedIn and board committees
- The full competitor set, tracking, exports and API access